IL1B and colitis: On the other hand, the animal group treated with curcumin nanostructured microemulsion had a significant reduction in the tissue levels of TNF-α (170.5 ± 5.01 pg/mL), as well as IL-1β and IL-6, compared to the colitis treated with NS, and to the COL/MES group rats.